D
Kane Biotech Inc. KNE.V
TSX
Recommendation
Sell
Prev Close
$0.095
Volume
--
Avg Vol (90D)
75,236
Market Cap
$10.22M
Dividend & Yield
--
52-Week Range
$0.085 - $0.17
P/E (TTM)
3.56
EPS (TTM)
$0.0267
My Lists My Alerts
Weiss Ratings KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating D
Reward Index Fair
Risk Index Weak
Risk Grade D-
Reward Grade C
Rating Factors KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Good
Solvency Index Very Weak
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -0.11
Price History KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 5.26%
30-Day Total Return -4.76%
60-Day Total Return -9.09%
90-Day Total Return -20.00%
Year to Date Total Return -9.09%
1-Year Total Return 0.00%
2-Year Total Return 0.00%
3-Year Total Return -20.00%
5-Year Total Return -45.95%
52-Week High % Change -44.12%
52-Week Low % Change 11.76%
Price KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.17
52-Week Low Price $0.09
52-Week Low Price (Date) Feb 25, 2025
52-Week High Price (Date) Apr 10, 2024
Valuation KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 10.22M
Enterprise Value 11.43M
Price/Earnings (TTM) 3.56
Earnings Per Share (TTM) 0.03
Earnings Per Share Growth -196.39%
Price/Earnings To Growth --
Price/Sales (TTM) 8.64
Price/Book (Q) -25.68
Enterprise Value/Revenue (TTM) 7.76
Price $0.10
Enterprise Value/EBITDA (TTM) -3.82
Enterprise Value/EBIT -3.77
Market Cap Category Nano Cap
Dividends and Shares KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 133.79M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 204-453-1301
Address 100 Innovation Drive Winnipeg, MB R3T 6G2
Website kanebiotech.com
Country Canada
Year Founded 2001
Profitability KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -205.79%
Profit Margin 278.48%
Management Effectiveness KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -51.70%
Return on Equity --
Income Statement KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 1.47M
Total Revenue (TTM) 1.47M
Revenue Per Share $0.01
Gross Profit (TTM) 727.40K
EBITDA (TTM) -2.99M
EBIT (TTM) -3.03M
Net Income (TTM) 4.10M
Net Income Avl. to Common (TTM) 4.10M
Total Revenue Growth (Q YOY) 4,579.10%
Earnings Growth (Q YOY) 46.35%
EPS Diluted (TTM) 0.03
EPS Diluted Growth (Q YOY) 15.85%
Balance Sheet KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 403.00K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 1.64M
Total Preferred Equity (Q) --
Total Equity (Q) -509.70K
Current Ratio (Q) 0.802
Book Value Per Share (Q) $0.00
Total Assets (Q) 2.89M
Total Current Liabilities (Q) 2.04M
Total Debt (Q) 1.70M
Total Liabilities (Q) 3.40M
Total Common Equity (Q) -509.70K
Cash Flow KNE.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) 6.59M
Cash from Financing (TTM) -4.11M
Net Change in Cash (TTM) -1.63M
Levered Free Cash Flow (TTM) -1.68M
Cash from Operations (TTM) -4.11M
Weiss Ratings